These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 26174047

  • 1. Transforming berberine into its intestine-absorbable form by the gut microbiota.
    Feng R, Shou JW, Zhao ZX, He CY, Ma C, Huang M, Fu J, Tan XS, Li XY, Wen BY, Chen X, Yang XY, Ren G, Lin Y, Chen Y, You XF, Wang Y, Jiang JD.
    Sci Rep; 2015 Jul 15; 5():12155. PubMed ID: 26174047
    [Abstract] [Full Text] [Related]

  • 2. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
    Wang Y, Shou JW, Li XY, Zhao ZX, Fu J, He CY, Feng R, Ma C, Wen BY, Guo F, Yang XY, Han YX, Wang LL, Tong Q, You XF, Lin Y, Kong WJ, Si SY, Jiang JD.
    Metabolism; 2017 May 15; 70():72-84. PubMed ID: 28403947
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction.
    Wang LL, Guo HH, Huang S, Feng CL, Han YX, Jiang JD.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul 01; 1057():70-80. PubMed ID: 28505492
    [Abstract] [Full Text] [Related]

  • 6. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.
    Buchanan B, Meng Q, Poulin MM, Zuccolo J, Azike CG, Gabriele J, Baranowski DC.
    PLoS One; 2018 Jul 01; 13(3):e0194979. PubMed ID: 29579096
    [Abstract] [Full Text] [Related]

  • 7. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
    Cheng Z, Chen AF, Wu F, Sheng L, Zhang HK, Gu M, Li YY, Zhang LN, Hu LH, Li JY, Li J.
    Bioorg Med Chem; 2010 Aug 15; 18(16):5915-24. PubMed ID: 20663675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Excretion of berberine and its metabolites in oral administration in rats.
    Ma JY, Feng R, Tan XS, Ma C, Shou JW, Fu J, Huang M, He CY, Chen SN, Zhao ZX, He WY, Wang Y, Jiang JD.
    J Pharm Sci; 2013 Nov 15; 102(11):4181-92. PubMed ID: 24006193
    [Abstract] [Full Text] [Related]

  • 11. The Effects of Berberine on the Gut Microbiota in Apc min/+ Mice Fed with a High Fat Diet.
    Wang H, Guan L, Li J, Lai M, Wen X.
    Molecules; 2018 Sep 08; 23(9):. PubMed ID: 30205580
    [Abstract] [Full Text] [Related]

  • 12. Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
    Sun J, Bao H, Peng Y, Zhang H, Sun Y, Qi J, Zhang H, Gao Y.
    Int J Pharm; 2018 Jun 10; 544(1):46-54. PubMed ID: 29654898
    [Abstract] [Full Text] [Related]

  • 13. Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.
    Wang Y, Tong Q, Shou JW, Zhao ZX, Li XY, Zhang XF, Ma SR, He CY, Lin Y, Wen BY, Guo F, Fu J, Jiang JD.
    Theranostics; 2017 Jun 10; 7(9):2443-2451. PubMed ID: 28744326
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota.
    Lyu Y, Zhang Y, Yang M, Lin L, Yang X, Cheung SCK, Shaw PC, Chan PKS, Kong APS, Zuo Z.
    Life Sci; 2019 Oct 15; 235():116818. PubMed ID: 31473193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y, Hu J, Geng J, Hu T, Wang B, Yan W, Jiang Y, Li J, Liu S.
    Biomed Pharmacother; 2018 Nov 15; 107():1556-1563. PubMed ID: 30257374
    [Abstract] [Full Text] [Related]

  • 18. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
    Yao Y, Chen H, Yan L, Wang W, Wang D.
    Biomed Pharmacother; 2020 Nov 15; 131():110669. PubMed ID: 32937246
    [Abstract] [Full Text] [Related]

  • 19. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
    Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, Hu LH, Li J, Ye JM.
    Diabetes; 2008 May 15; 57(5):1414-8. PubMed ID: 18285556
    [Abstract] [Full Text] [Related]

  • 20. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
    Fang Y, Zhang J, Zhu S, He M, Ma S, Jia Q, Sun Q, Song L, Wang Y, Duan L.
    Pharmacol Res; 2021 Mar 15; 165():105439. PubMed ID: 33493658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.